151 related articles for article (PubMed ID: 31591828)
1. Risk assessment of macrovascular and microvascular events in patients with type 2 diabetes by analyzing the amplitude variation of the fourth harmonic component of radial pulse wave.
Liao KM; Chang CW; Wang SH; Chang YT; Chen YC; Wang GC
Physiol Rep; 2019 Oct; 7(19):e14252. PubMed ID: 31591828
[TBL] [Abstract][Full Text] [Related]
2. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
[TBL] [Abstract][Full Text] [Related]
3. The first harmonic of radial pulse wave predicts major adverse cardiovascular and microvascular events in patients with type 2 diabetes.
Liao KM; Chang CW; Wang SH; Chang YT; Chen YC; Wang GC
J Diabetes Complications; 2019 Nov; 33(11):107420. PubMed ID: 31488349
[TBL] [Abstract][Full Text] [Related]
4. Fourth harmonic of radial pulse wave predicts adverse cardiac events in asymptomatic patients with type 2 diabetes.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
J Diabetes Complications; 2019 Jun; 33(6):413-416. PubMed ID: 30981433
[TBL] [Abstract][Full Text] [Related]
5. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
Hata J; Arima H; Rothwell PM; Woodward M; Zoungas S; Anderson C; Patel A; Neal B; Glasziou P; Hamet P; Mancia G; Poulter N; Williams B; Macmahon S; Chalmers J;
Circulation; 2013 Sep; 128(12):1325-34. PubMed ID: 23926207
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
7. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
[TBL] [Abstract][Full Text] [Related]
8. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
Sharif S; Visseren FLJ; Spiering W; de Jong PA; Bots ML; Westerink J;
Diabet Med; 2019 Sep; 36(9):1125-1132. PubMed ID: 30920676
[TBL] [Abstract][Full Text] [Related]
9. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes.
Herrmann M; Sullivan DR; Veillard AS; McCorquodale T; Straub IR; Scott R; Laakso M; Topliss D; Jenkins AJ; Blankenberg S; Burton A; Keech AC;
Diabetes Care; 2015 Mar; 38(3):521-8. PubMed ID: 25524951
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Mohammedi K; Woodward M; Marre M; Colagiuri S; Cooper M; Harrap S; Mancia G; Poulter N; Williams B; Zoungas S; Chalmers J
Cardiovasc Diabetol; 2017 Jul; 16(1):95. PubMed ID: 28750645
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
[TBL] [Abstract][Full Text] [Related]
13. Visit-to-visit variability of blood pressure and risk of macrovascular and microvascular complications in patients with type 2 diabetes: A Chinese primary-care cohort study.
Deng Y; Liu Y; Zhang S; Yu H; Zeng X; An R; Chen Z; Sun N; Yin X; Dong Y
J Diabetes; 2022 Nov; 14(11):767-779. PubMed ID: 36443961
[TBL] [Abstract][Full Text] [Related]
14. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
15. The First Harmonic of Radial Pulse as an Early Predictor of Silent Coronary Artery Disease and Adverse Cardiac Events in Type 2 Diabetic Patients.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
Cardiol Res Pract; 2018; 2018():5128626. PubMed ID: 30425857
[TBL] [Abstract][Full Text] [Related]
16. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
Zoungas S; Woodward M; Li Q; Cooper ME; Hamet P; Harrap S; Heller S; Marre M; Patel A; Poulter N; Williams B; Chalmers J;
Diabetologia; 2014 Dec; 57(12):2465-74. PubMed ID: 25226881
[TBL] [Abstract][Full Text] [Related]
17. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
[TBL] [Abstract][Full Text] [Related]
18. Differential associations of central and brachial blood pressure with carotid atherosclerosis and microvascular complications in patients with type 2 diabetes.
Jung CH; Jung SH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO
BMC Cardiovasc Disord; 2014 Feb; 14():23. PubMed ID: 24555866
[TBL] [Abstract][Full Text] [Related]
19. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
[TBL] [Abstract][Full Text] [Related]
20. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
